Abstract
The present study investigates the correlation between the hypoxia-induced phosphorylation of cyclic AMP response element binding protein and the expression of apoptotic proteins (proapoptotic proteins Bax and Bad and antiapoptotic proteins Bcl-2 and Bcl-xl) during hypoxia in the cerebral cortex of newborn piglets. Piglets were divided into normoxic (Nx) and hypoxic (Hx, FiO2 = 0.06 for 1 h) groups. Cerebral tissue hypoxia was documented by ATP and phosphocreatine (PCr) levels. Ser133 phosphorylation of cyclic AMP response element binding (CREB) protein was determined by Western blot analysis using a specific anti-phosphorylated Ser133-CREB protein antibody. The expression of apoptotic proteins was determined by using specific anti-Bax, anti-Bad, anti-Bcl-2 and anti-Bcl-xl antibodies. ATP and PCr values (μmoles/g brain) in Hx were significantly different from Nx (ATP: 4.40 ± 0.39 in Nx vs. 1.19 ± 0.44 in Hx, P < 0.05 vs. Nx; PCr: 3.60 ± 0.40 in Nx vs. 0.70 ± 0.31 in Hx, P < 0.05 vs. Nx). Ser133 phosphorylated CREB protein (OD × mm2) was 74.55 ± 4.75 in Nx and 127.13 ± 19.36 in Hx (P < 0.05 vs. Nx). The expression of proapoptotic proteins Bax and Bad increased and strongly correlated with the increase in CREB protein phosphorylation (correlation coefficient r = 0.82 and r = 0.85, respectively). The expression of antiapoptotic proteins Bcl-2 and Bcl-xl did not show correlation with CREB protein phosphorylation. We conclude that cerebral hypoxia results in differential regulation of CREB protein-mediated expression of proapoptotic and antiapoptotic proteins in the cerebral cortex of newborn piglets. We propose that the increased expression of proapoptotic vs antiapoptotic genes will lead to an increased potential for apoptotic programmed cell death in the Hx newborn brain.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Intranuclear Ca++ regulates a number of critical nuclear functions including regulation of transcription factors, cell cycle regulation, gene transcription, DNA replication and nuclear envelope breakdown [1, 2]. Furthermore, nuclear Ca++ signals potentially control a number of events leading to hypoxia-induced programmed cell death. Nuclear and cytosolic Ca++ signals are differentially regulated, and the extranuclear Ca++ concentration determines the mode of Ca++ entry into the nucleus.
The increased intracellular Ca++ is a primary mediator of activity-dependent gene transcription under a number of experimental conditions [3–6]. The patterns of neuronal impulse and the specific properties of the stimulus-induced calcium transients determine the nature and amplitude of the genomic response [5, 7]. Several factors including the site of calcium entry, the amplitude and the spatial properties of the calcium signals determine the calcium regulated gene expression [8–13]. Furthermore, the duration of calcium signal also contributes to the specificity of the transcription induction. In cells of the immune system only a continuous rise in intracellular Ca++ concentration, but not a brief spike, induced translocation of transcription factors, NF-ATc [14]. It was demonstrated that gene expression in neurons is also determined by the duration of calcium transients and the activity-dependent transcription is regulated by the duration of calcium transients [6].
In previous studies we have shown that cerebral hypoxia results in increased nuclear Ca++-influx in neuronal nuclei of the cerebral cortex of newborn piglets [15, 16]. The nuclear Ca++-influx increased as a function of increase in cerebral tissue hypoxia, as measured by decrease in high energy phosphates, ATP and phosphocreatine (PCr). We have demonstrated that cerebral hypoxia results in increased Ca++/calmodulin kinase (CaM kinase) IV activity and increased cyclic AMP response element binding (CREB) protein phosphorylation in neuronal nuclei of newborn piglets [17, 18].
Previously, we have shown that hypoxia results in increased expression of apoptotic proteins in the cerebral cortex of newborn piglets. Bcl-2 family of proteins (including Bcl-2 and Bax) control cell proliferation, differentiation and programmed cell death during normal brain development [19–21]. Bax and Bcl-2 are inducible genes found in the developing and adult central and peripheral nervous systems [22–24]. Bcl-2 prevents apoptosis by forming a heterodimer with the proapoptotic protein Bax and protects cells from programmed cell death following hypoxia [19–21].
The present study specifically focuses on investigating during hypoxia the relationship between phosphorylation of CREB protein at Ser133 and the expression of proapoptotic proteins Bax and Bad, and antiapoptotic proteins Bcl-2 and Bcl-xl in neuronal nuclei of the cerebral cortex of newborn piglets. In the present study we have tested the hypothesis that hypoxia-induced increase in phosphorylation of CREB protein at Ser133 has a strong correlation with the expression of proapoptotic proteins. On the basis of our previous studies we anticipate a relationship between CREB protein phosphorylation and proapoptotic protein expression.
Materials and methods
Animal experimentation and induction of hypoxia
Studies were performed on 3–5 day old Yorkshire piglets obtained from the Willow Glenn Farm, Strausburg, PA. The experimental animal protocol was approved by the Institutional Animal Care and Use Committee of Drexel University. Newborn piglets were randomly assigned to one of two groups: normoxic (Nx) (n = 6) and hypoxic (Hx) (n = 6). The animals were ventilated for 1 h under either Nx condition (FiO2 = 0.21) or Hx condition; hypoxia was induced by lowering the FiO2 to 0.07 for 60 min. At the end of the experimental period, the animal was sacrificed; the cortical tissue was removed and placed either in homogenization buffer for isolation of neuronal nuclei or in liquid nitrogen, and then stored at −80°C for later biochemical studies.
Isolation of cerebral cortical neuronal nuclei
Cerebral neuronal nuclei were isolated and purified according to the methods of Giuffrida et al. 1975 [25] and purified as described by Austoker et al. 1972 [26]. Cortical tissue was homogenized by habd ib Dounce-type glass homogenizer (200 ± m clearance) in 22 strokes in 15 volumes of a medium containing 0.32 M sucrose, 10 mM Tris–HCl (pH 6.8) and 1 mM MgCl2 to achieve a final concentration of 2.1 M sucrose, at which neuronal nuclei are settled. The nuclei were then purified by centrifuging at 53,000g for 60 min . All procedures were carried out at 4°C. The nuclear pellet was suspended in the medium (0.32 M sucrose, 10 mM Tris–HCl buffer, pH 6.8 and 1 mM MgCl2) and the purity of neurona nuclei was assessed by phase contrast microscope (Olympus, Melville, NY, USA). The neuronal nuclei were characterized by the presence of a centrally located nucleolus (one nucleolus/nucleus) as compared with the presence of multi-nucleoli in the astrocytic and oligodendrocytic nuclei. The final nuclear preparation was devoid of any microsomal, mitochondrial or plasma membrane contaminant with a purity for neuronal nuclei of 90%. Protein content was determined by the method of Lowry et al. 1951 [27]. The nuclear membrane preparation was diluted to a final concentration of 100 μg protein/100 μl.
Immunoprecipitation and western blot analysis of Ser133-CREB protein phosphorylation and pro-and antiapoptotic proteins Bax, Bad, Bcl-2 and Bcl-xl
Neuronal nuclear membranes were prepared as described above in the presence of protease inhibitors [1 mM phenylmethylsulfonyl fluoride (PMSF), 10 μg/ml aprotinin and 0.2 mM sodium orthovanadate]. Protein content was determined by the method of Lowry et al. 1951 [27], and the nuclear membrane preparation was diluted to a final concentration of 100 μg/100 μl. The membrane protein was solubilized in modified RIPA buffer [50 mM Tris–HCl (pH 7.4), 1 mM EDTA, 150 mM NaCl, 1% Nonidet P-40, 0.25% sodium deoxycholate, 1 mM PMSF, 1 mM Na3VO4, 1 mM NaF and 1 μg/ml each of apoprotein, leupeptin and pepstatin]. Equal amounts of each neuronal nuclear protein were separated by 12% sodium dodecyl sulfate–polyacrylamide gel electrophoresis and transferred electrophoretically to nitrocellulose membranes. Nitrocellulose membranes in duplicate were then blocked with 10% non-fat milk in phosphate-buffered saline. The membranes were subsequently incubated with anti-phosphorylated (serine-133) CREB protein antibody (Upstate Biotechnology, Lake Placid, NY, USA) or specific anti-Bax, anti-Bad, anti-Bcl-2 and anti-Bcl-xl antibodies (Upstate Biotechnology, Lake Placid, NY, USA). Immunoreactivity was then detected by incubation with horseradish peroxidase-conjugated secondary antibody (Rockland, Gilbertsville, PA, USA). Specific complexes were detected by enhanced chemiluminescence method using the ECL detection system (Amersham Pharmacia Biotech, Buckinghamshire, UK) and analyzed by imaging densitometry (GS-700 densitometer, Bio-Rad). The densitometric scanning data were expressed as autoradiographic values (OD × mm2) per immunoblot protein representing CREB protein phosphorylation. In another set, CREB protein expression was also determined by anti-CREB antibody using the above method.
Determination of ATP and phosphocreatine
ATP and PCr concentrations were determined according to the method of Lamprecht et al. 1974 [28].
Statistical analysis
Data was analyzed using one way analysis of variance ANOVA to compare Nx and Hx groups. A P value of less than 0.05 was considered statistically significant. All values are presented as mean ± standard deviation (SD).
Results
Brain tissue hypoxia in piglets was documented by determining the ATP and PCr levels in the cerebral cortical tissue. ATP values (μmoles/g brain) decreased from 4.40 ± 0.39 in Nx to 1.19 ± 0.44 in Hx (P < 0.05 vs. Nx). PCr values (μmoles/g brain) decreased from 3.60 ± 0.40 in Nx to 0.70 ± 0.31 in Hx (P < 0.05 vs. Nx). The level of high energy phosphates decreased significantly in the Hx group as compared to Nx and the data demonstrate that cerebral tissue hypoxia was achieved in the Hx group.
CREB protein phosphorylation at Ser133 in neuronal nuclei of Nx and Hx groups are shown in Fig. 1. The relationship of CREB protein phosphorylation with the cerebral high energy phosphates ATP and PCr are shown in Fig. 1. The results show an increased phosphorylation of CREB protein as afunction of decrease in high energy phosphates during hypoxia in the cerebral cortical neuronal nuclei of newborn piglets. These results confirm our previous findings that cerebral hypoxia results in increased CREB protein phosphorylation with decreased high energy phosphates.
The expression of proapoptotic proteins Bax and Bad were plotted against increasing concentrations of phosphorylated CREB protein. The relationship of CREB protein phosphorylation with the expression of Bax and Bad is shown in Fig. 2. The results show an increased expression of Bax and Bad with increase in phosphorylation of CREB protein at Ser133. The data show a strong correlation between CREB protein phosphorylation and the expression of proapoptotic proteins Bax and Bad (correlation coefficient: r = 0.82 and r = 0.85, respectively). These results demonstrate that expression of proapoptotic proteins increases as a function of increase in CREB protein phosphorylation on Ser133 during hypoxia in neuronal nuclei of the cerebral cortex of newborn piglets.
The expression of antiapoptotic proteins Bcl-2 and Bcl-xl were plotted against increasing concentrations of phosphorylated CREB protein. The relationship of CREB protein phosphorylation with the expression of Bcl-2 and Bcl-xl is shown in Fig. 3. The results show that hypoxia does not result in increased expression of Bcl-2 and Bcl-xl. The data do not show a correlation between CREB protein phosphorylation and the expression of antiapoptotic proteins Bcl-2 and Bcl-xl (correlation coefficient: r = 0.82 and r = 0.85, respectively). These results demonstrate that the expression of antiapoptotic proteins did not increase during hypoxia and had no correlation with the phosphorylation of CREB protein in neuronal nuclei of the cerebral cortex of newborn piglets. These results indicate differential expression of pro- and antiapoptotic proteins during hypoxia in the cerebral cortex of newborn piglets.
Discussion
Intracellular Ca++ is a critical mediator of hypoxic-ischemic neuronal excitotoxicity. The Ca++-dependent neuronal damage is due to NMDA receptor-mediated excitotoxicity that is initiated as a result of hypoxia. During hypoxia an increase in intracellular Ca++ is a result of the NMDA receptor ion-channel-mediated Ca++-influx as well as the release of Ca++ from intracellular stores such as mitochondria and the endoplasmic reticulum [29]. Previously, we have shown that cerebral hypoxia results in increased nuclear Ca++-influx, increased CaM kinase IV activity and increased phosphorylation of CREB protein at Ser133 in neuronal nuclei of the cerebral cortex of newborn piglets. The present study tests the hypothesis that cerebral hypoxia-induced increased CREB phosphorylation correlates with the expression of proapoptotic proteins in the cerebral cortex of newborn piglets.
The results of the present study show that cerebral hypoxia results in increased phosphorylation of CREB protein at Ser133 in neuronal nuclei of the cerebral cortex of newborn piglets. The data presented in the graphs show a strong correlation between CREB protein phosphorylation and the expression of proapoptotic proteins Bax and Bad. There is no correlation between CREB phosphorylation with the expression of antiapoptotic proteins Bcl-2 and Bcl-xl. These results show a differential effect of hypoxia on the CREB mediated transcription of pro- and anti-apoptotic genes of the same Bcl-2 gene family. This is quite interesting to note how cerebral hypoxia can have such a selective effect on transcription mediated by CREB.
CaM kinase IV is present in nucleus and activates transcription factors including CREB protein. The importance of CaM kinases in transcription was supported by the observation that Ca++-dependent transcription of three immediate early genes (c-fos, NGFI-A, and NGFI-B) was blocked by the CaM kinase inhibitor KN-62 [30]. CaM kinase IV is a member of CaM kinase cascade and is predominantly located in the nucleus, and along with CaM kinase kinase is abundant in the brain. CaM kinase kinase and CaM kinase IV mediate Ca++-regulated gene expression by activating CREB. CaM kinases are activated by a conformational change induced by binding to Ca++/calmodulin complex, which in turn results in decreased interference of auto-inhibitory domain of CaM kinase with its active site. CaM kinase kinase activates CaM kinase IV, via phosphorylation of Thr200 or Thr196 in a process that requires Ca++/calmodulin and ATP/Mg++. Activated CaM kinase IV mediates Ca++-regulated transcription by phosphorylating and activating CREB protein at Ser133 in a cyclic-AMP-independent process.
The CaM kinase cascade, leading to activation of transcription can be regulated at different points. The activity of CaM kinase IV is tightly regulated by protein kinases and protein phosphatases. First, CaM kinase kinase, the activator of CaM kianse IV, is inactivated when phosphorylated by CaM kinase I, CaM kinase IV or protein kinase A. Second, CaM kinase IV can be inactivated by protein phosphatase 2A. Third, protein serine/threonine phosphatases (protein phosphatase 1, protein phosphatase 2A and protein phosphatase 2B) can dephosphorylate CREB at Ser133 causing termination of transcriptional activity. In addition CREB activation can also be blocked by CaM kinase II dependent phosphorylation at Ser142 that blocks the activation of CREB. The differential response of hypoxia on the expression of proapoptotic and antiapoptotic proteins could be due to the differential effect on mRNA translation of these specific genes.
As observed in this study during hypoxia, overexpression of Bax or an increase in the ratio of Bax to Bcl-2, is associated with cells undergoing programmed cell death [21]. Up-regulation of Bax and/or down-regulation of Bcl-2 mRNA or protein levels have been observed in several experimental models including transient global ischemia [22, 31, 32]; the expression of Bax and Bcl-2 genes may be regulated by p53 [33]. Using a permanent middle cerebral artery occlusion model, DNA breaks occurred within 6 h and levels of Bax mRNA significantly increased within the infarcted hemisphere, indicating a shift in the gene expression ratio of Bcl-2 to Bax [31]. Using immunohistochemistry before and after 10 min of global ischemia, there were high levels of Bax, low levels of Bcl-2, and DNA-strand breaks in the same population of neurons found to be degenerating morphologically [34]. Neurons with elevated Bax levels almost uniformly had morphologic evidence of ischemic degeneration with apoptotic features including nuclear DNA fragmentation [24].
The increased Bax/Bcl-2 ratio favoring an increase in free Bax and promoting cell death observed during post-hypoxic reoxygenation can also be attributed to phosphorylation of Bcl-2 in neuronal nuclear membranes where phosphorylation of Bcl-2 compromises its anti-apoptotic potential [35]. Bax and Bcl-2 are located primarily in the membranes of the nuclear envelope, mitochondria, and parts of the endoplasmic reticulum [30, 36]. Bax and Bcl-2 within the nuclear membrane help regulate the intranuclear Ca2+ concentration to be independent of the cytosolic Ca2+ concentrations [37]. Mitochondrial membrane Bcl-2 does not prevent cell death by directly altering mitochondrial function [32], but instead by blocking release of cytochrome c from the mitochondria into the cytosol [38–40]. However, programmed cell death can occur in cells without mitochondrial DNA and these cells can be protected from apoptosis by the over expression of Bcl-2, suggesting that neither apoptosis nor the protective effect of Bcl-2 depends solely on mitochondria [32].
In a series of studies, we have demonstrated that administration of nitric oxide synthase (NOS) inhibitor, N-nitro-l-arginine (NNLA) prevented the hypoxia-induced increase in CaM kinase IV activity, increase in CREB phosphorylation, increase in the expression of pro-apoptotic protein Bax and increased fragmentation of nuclear DNA [17, 18, 41]. During hypoxia, NO and superoxide radicals are concurrently produced. NO produces peroxynitrite on combining with superoxide. The rate of reaction between NO and superoxide is several orders of magnitude faster than the reaction between superoxide and superoxide dismutase. Therefore, the production of peroxynitrite is favored over dismutation of superoxide. Thus NO produced during hypoxia may result in nitrosylation as well as peroxynitrite-mediated nitration of a number of proteins including proapoptotic and antiapoptotic proteins.
Nitric oxide is a critical mediator of neuronal injury as evidenced by the administration of pharmacological inhibitors of NOS that reduce neuronal injury from focal ischemia, NMDA dependent excitotoxicity and cerebral hypoxia [42–44]. Mice deficient in nNOS gene exhibit significant protection against cerebral ischemia and NMDA-mediated neurotoxicity [42, 43] Furthermore, cerebral hypoxia results in the generation of NO free radicals [45]. In addition, administration of NOS inhibitor prevented the hypoxia-induced generation of free radicals, nitration of the NMDA receptor subunits, CaM kinase IV activation, increased phosphorylation of cAMP response element binding (CREB) protein at Ser133 , increased expression of apoptotic protein Bax and fragmentation of nuclear DNA [18, 41, 44, 46].
We have shown that the activity of PP and PP2A are decreased during hypoxia in the cerebral cortex of newborn piglets [47]. The decrease in phosphatase activity could be due to NO-mediated modification of cysteine residue in the enzyme protein. We have also shown that cerebral hypoxia results in inhibition of mitogen activated protein (MAP) kinase phosphatase-1 and MAP kinase phosphatase-3 in the cerebral cortex of newborn piglets and the hypoxia-induced decrease in MAP kinase phosphtase-1 and -3 is mediated by NO. Therefore, NO produced during hypoxia may mediate modification of pro= and ant-apoptotic proteins by phosphorylation/dephosphorylation mechanisms.
In view of these observations, NO can play a central role in Hx neuronal death by both the necrotic as well as apoptotic or programmed cell death mechanisms. First, the NO-induced increase in NMDA receptor mediated intracellular Ca++ potentially initiates a number of reactions leading to increased free radical generation via a number of enzymatic pathways such as Ca++ activation of phospholipase A2, causing release of arachidonic acid which then can be metabolized by cyclooxygenase and lipoxygenase, the conversion of xanthine dehydrogenase to xanthine oxidase by Ca++-dependent activation of proteases and activation of nitric oxide synthase by Ca++ to further generate NO leading to formation of peroxynitrite and oxygen free radical species. The increased free radicals generated result in increased peroxidation of cellular and sub-cellular membranes leading to necrotic cell death. Second, the increased intracellular Ca++ may lead to increased intranuclear Ca++ by mechanisms of Ca++-influx such as the IP3 receptors and the nuclear membrane high affinity Ca++ ATPase. Furthermore, we have demonstrated that NO increases nuclear Ca++ influx. Increased intranuclear Ca++ may activate Ca++-dependent endonucleases leading to DNA fragmentation. In addition, increased intranuclear Ca++ by activating CaM kinase IV and increased phosphorylation of CREB protein resulting in increased transcription of proapoptotic genes such as Bax and Bad, and initiating the early events of DNA fragmentation and programmed cell death. Thus a central role for NO is proposed in regulating neuronal function in Hx neuronal death, by altering the nuclear membrane mechanisms of Ca++-influx resulting in increased CaM kinase activity and subsequent increased phosphorylation of CREB protein at Ser133.
In summary: These results show that hypoxia results in increased phosphorylation of CREB protein at Ser133 in neuronal nuclei of the cerebral cortex of newborn piglets. The results demonstrate a strong correlation between the CREB protein phosphorylation at Ser133 and the expression of proapoptotic proteins Bax and Bad. There was no correlation between CREB protein phosphorylation and the expression of antiapoptotic proteins Bcl-2 and Bcl-xl. The results of this study show a selective hypoxia-induced expression of proapoptotic proteins vs antiapoptotic proteins that would result in an increased ratio of pro-/antiapoptotic proteins leading to increased potential for the initiation of programmed cell death in the Hx brain. We conclude that hypoxia results in a differential expression of pro- and anti-apoptotic proteins in neuronal nuclei of the cerebral cortex of newborn piglets.
References
Mishra OP, Delivoria-Papadopoulos M (1999) Cellular mechanisms of hypoxic injury in the developing brain. Brain Res Bull 48:233–238
Delivoria-Papadopoulos M, Mishra OP (2004) Nuclear mechanisms of hypoxic cerebral injury in the newborn. Clin Perinatol 31:91–105
Ghosh A, Greenberg ME (1995) Calcium signaling in neurons: molecular mechanisms and cellular consequences. Science 268:239–247
Bito H, Deisseroth K, Tsien RW (1997) Ca++-dependent regulation in neuronal gene expression. Curr Opin Neurobiol 7:419–429
Hardigham GE, Bading H (1998) Nuclear calcium: a key regulator of gene expression. Biometals 11:345–358
Chawla S, Bading H (2001) CREB/CBP and SRE-interacting transcriptional regulators are fast on-off switches: duration of calcium transients specifies the magnitude of transcriptional responses. J Neurochem 79:849–858
Fields RD, Esthete F, Stevens B, Itoh K (1997) Action potential-dependent regulation of gene expression: temporal specificity in calcium cyclic AMP-responsice element binding proteins, and mitogen-activated protein kinase signaling. J Neurosci 17:7252–7266
Lerea LS, Butler LS, McNamar JO (1992) NMDA and non-NMDA receptor-mediated increase of c-fos mRNA in dentate gyrus neurons involved calcium influx via different routes. J Neurosci 12:2973–2981
Bading H, Ginty DD, Greenberg ME (1993) Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways. Science 260:181–186
Lerea LS, McNamara JO (1993) Ionotropic glutamate receptor subtypes activate c-fos transcription by distinct calcium requiring intracellular signaling pathways. Neuron 10:31–41
Hardigham GE, Chawla S, Johnson CM, Bading H (1997) Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression. Nature 385:260–265
Hardigham GE, Chawla S, Cruzalegui FH, Bading H (1999) Control of recruitment and transcription activating function of CBP determined gene regulation by NMDA receptor and L-type calcium channels. Neuron 22:789–798
Dolmetsch RE, Pajvani U, Fife K, Spotts JM, Greenberg ME (2001) Signaling to the nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase pathway. Science 294:333–339
Dolmetsch RE, Lewis RS, Goodnow CC, Healy JI (1997) Differential activation of transcrition factors induced Ca++ response amplitude and duration. Nature 386:855–858
Mishra OP, Delivoria-Papadopoulos M (2002) Nitric oxide mediated Ca++-influx in neuronal nuclei and cortical synaptosomes of normoxic and hypoxic newborn piglets. Neurosci Lett 318:93–97
Delivoria-Papadopoulos M, Akhter W, Mishra OP (2003) Hypoxia-induced Ca++-influxin cerebral cortical neuronal nuclei of newborn piglets. Neurosci Lett 342:119–123
Zubrow AB, Delivoria-Papadopoulos M, Ashraf QM, Fritz KI, Mishra OP (2002) Nitric oxide-mediated Ca++/calmodulin-dependent protein kinase IV activity during hypoxia in neuronal nuclei from newborn piglets. Neurosci Lett 335:5–8
Mishra OP, Ashraf QM, Delivoria-Papadopoulos M (2002) Phosphorylation of cAMP response element binding (CREB) protein during hypoxia in cerebral cortex of newborn piglets and the effect of nitric oxide synthase inhibition. Neuroscience 115:985–991
Farlie PG, Dringen R, Rees SM, Kannourakis G, Bernard O (1995) Bcl-2 transgene expression can protect neurons against developmental and induced cell death. Proc Natl Acad Sci USA 92:4397–4401
Martinou J-C, Dubois-Dauphin M, Staple JK, Rodriquez I, Frankowski H, Missotten M, Albertini P, Talabot D, Catsicas S, Pietra C, Huarte J (1994) Over expression of Bcl-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13:1017–1030
Oltvai ZN, Milliman CM, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609–619
Chen J, Zhu RL, Nakayama M, Kawaguchi K, Jin K, Stetler RA, Simon RP, Graham SH (1996) Expression of the apoptosis-effector gene, Bax, is up-regulated in vulnerable hippocampal CA1 neurons following global ischemia. J Neurochem 67:64–71
Merry DE, Veis DJ, Hickey WF, Korsmeyer SJ (1994) Bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development 120:301–311
Reed JC (1996). Mechanisms of Bcl-2 family protein function and dysfunction in health and disease. Behring Inst Mitt 97:72–100
Giuffrida AM, Cox D, Mathias AP (1975) RNA polymerase activity invarious classes of nuclei from different regions of rat brain during postnatal development. J Neurochem 24:749–755
Austoker J, Cox D, Mathias P (1972) Fractionation of nuclei from brain by zonal centrifugation and a study of ribonucleic acid polymerase activity in the various classes of nuclei. Biochem J 129:1139–1155
Lowry OH, Rosenbrough NJ, Farr AL, Randal RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Lamprechet W, Stein P, Heinz F, Weissner H (1974) Creatine phosphate. In: Bergmeyer HU (ed) Methods of enzymatic Analysis, vol 4. Academic Press, New York, pp 1777–1781
Frandsen A, Schousboe A (1991) Dantrolene prevents cytotoxicity and Ca++ release from intracellular stores in cultured cerebral cortical neurons. J Neurchem 56:1075–1078
Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC (1993) Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 53:4701–4714
Gillardon F, Lenz C, Waschke KF, Krajewski S, Reed JC, Zimmermann M, Kuschinsky W (1996) Altered expression of Bcl-2, Bcl-X, Bax, and c-Fos colocalizes with DNA fragmentation and ischemic cell damage following middle cerebral artery occlusion in rats. Mol Brain Res 40:254–260
Jacobson MD, Burne JF, King MP, Miyashita T, Reed JC, Raff MC (1993) Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 361:365–369
Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799–1805
Krajewski S, Mal JK, Krajewska M, Sikorska M, Mossakowski MJ (1995) Upregulation of Bax protein levels in neurons following cerebral ischemia. J Neurosci 15:6364–6376
Ashraf QM, Zanelli S, Mishra OP, Delivoria-Papadopoulos M (2001) Phosphorylation of Bcl-2 and Bax proteins during hypoxia in newborn piglets. Neurochem Res 26:1–9
Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334–336
Marin MC, Fernandez A, Brick RJ, Brisbay S, Buja LM, Snuggs M, McConkey DJ, von Eschenbach AC, Keating MJ, McDonnell ATJ (1996) Apoptosis suppression by bcl-2 is correlated with the regulation of nuclear and cytosolic Ca2+. Oncogene 12:2259–2266
Kharbandra S, Pandey P, Schofield L, Israels S, Roncinske R, Yoshida K, Bharti A, Yuan ZM, Saxena S, Weichselbaum R (1997) Role of Bcl-xl as an inhibitor of cytosolic cytochrome c accumulation in DNA damage-induced apoptosis. Proc Natl Acad Sci USA 94:6939–6942
Kim CN, Wang X, Huang Y, Ibrado AM, Liu L, Fang G, Bhalla K (1997) Over expression of Bcl-X(L) inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis. Cancer Res 57:3115–3120
Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479–489
Zubrow AB, Delivoria-Papadopoulos M, Ashraf QM, Ballesteros JR, Fritz KI, Mishra OP (2002) Nitric oxide-mediated expression of Bax protein and DNA fragmentation during hypoxia in neuronal nuclei from newborn piglets. Brain Res 954:60–67
Huang Z, Huang PL, Panathian N, Dalkara T, Fishman MC, Moskowitz MA (1994) Effects of cerebral ischemiain mice deficient in neuronal nitric oxide synthase. Science 265:1183–1885
Yun H-Y, Dawson VL, Dawson TM (1997) Nitric oxide in health and diseases of the nervous system. Mol Psychiatr 2:300–310
Numagami Y, Zubrow AB, Mishra OP, Delivoria-Papadopoulos M (1997) Lipid free radical generation and brain cell membrane alteration following nitric oxide synthase inhibition during cerebral hypoxia in the newborn piglet. J Neurochem 69:1542–1547
Mishra OP, Zanelli SA, Ohnishi ST, Delivoria-Papadopoulos M (2000) Hypoxia-induced generation of nitric oxide free radicals in cerebral cortex of newborn guinea pigs. Neurochem Res 25:1559–1565
Zanelli SA, Ashraf QM, Mishra OP (2002) Nitration is a mechanism of regulation of the NMDA receptor function during hypoxia. Neurosci 112:869–877
Truttman AC, Ashraf Q, Mishra OP, Delivoria-Papadopoulos M (2004) Effect of hypoxia on protein phsphatase 2A activity, subcellular distribution and expression in cerebral cortex of newborn piglets. Neuroscience 127:355–363
Acknowledgments
This study was supported by the National Institute of Health grants HD-38079 (OPM) and HD-20337 (MDP). The authors thank Mrs. Joanna Kubin for her expert technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Delivoria-Papadopoulos, M., Ashraf, Q.M. & Mishra, O.P. Differential Expression of Apoptotic Proteins Following Hypoxia-induced CREB Phosphorylation in the Cerebral Cortex of Newborn Piglets. Neurochem Res 32, 1256–1263 (2007). https://doi.org/10.1007/s11064-007-9301-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-007-9301-5